| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-01-06 06:31:25 UTC |
|---|
| Updated at | 2021-07-15 17:35:51 UTC |
|---|
| NP-MRD ID | NP0021252 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Oxetanocin |
|---|
| Provided By | NPAtlas |
|---|
| Description | Oxetanocin A is also known as NK 84-0218. Oxetanocin A is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Oxetanocin is found in Bacillus. Oxetanocin was first documented in 1986 (PMID: 3793633). Based on a literature review very few articles have been published on Oxetanocin A (PMID: 2787618) (PMID: 3025147) (PMID: 33674826) (PMID: 33560833). |
|---|
| Structure | [H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=NC3=C2N=C([H])N=C3N([H])[H])[C@]1([H])C([H])([H])O[H] InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-5(1-16)6(2-17)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6-,10-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (-)-Oxetanocin | ChEBI | | (-)-Oxetanocin a | ChEBI | | 9-((2'r,3'r,4's)-3',4'-Bis(hydroxymethyl)-2'-oxetanyl)adenine | ChEBI | | 9-[(2R,3R,4S)-3,4-Bis(hydroxymethyl)-2-oxetanyl]adenine | ChEBI | | NK 84-0218 | ChEBI | | Oxetanocin | ChEBI | | 9-(3,4-Bis(hydroxymethyl)-2-oxetanyl)adenine | MeSH |
|
|---|
| Chemical Formula | C10H13N5O3 |
|---|
| Average Mass | 251.2460 Da |
|---|
| Monoisotopic Mass | 251.10184 Da |
|---|
| IUPAC Name | [(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methanol |
|---|
| Traditional Name | [(2S,3R,4R)-4-(6-aminopurin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methanol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@H]1CO |
|---|
| InChI Identifier | InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-5(1-16)6(2-17)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6-,10-/m1/s1 |
|---|
| InChI Key | LMJVXGOFWKVXAW-OXOINMOOSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Bacillus | NPAtlas | |
|
|---|
| Species Where Detected | |
|---|
| Chemical Taxonomy |
|---|
| Classification | Not classified |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Nakamura H, Hasegawa S, Shimada N, Fujii A, Takita T, Iitaka Y: The X-ray structure determination of oxetanocin. J Antibiot (Tokyo). 1986 Nov;39(11):1626-9. doi: 10.7164/antibiotics.39.1626. [PubMed:3793633 ]
- Seki J, Shimada N, Takahashi K, Takita T, Takeuchi T, Hoshino H: Inhibition of infectivity of human immunodeficiency virus by a novel nucleoside, oxetanocin, and related compounds. Antimicrob Agents Chemother. 1989 May;33(5):773-5. doi: 10.1128/AAC.33.5.773. [PubMed:2787618 ]
- Shimada N, Hasegawa S, Harada T, Tomisawa T, Fujii A, Takita T: Oxetanocin, a novel nucleoside from bacteria. J Antibiot (Tokyo). 1986 Nov;39(11):1623-5. doi: 10.7164/antibiotics.39.1623. [PubMed:3025147 ]
- Ye Y, Fu H, Hyster TK: Activation modes in biocatalytic radical cyclization reactions. J Ind Microbiol Biotechnol. 2021 Jun 4;48(3-4). pii: 6155068. doi: 10.1093/jimb/kuab021. [PubMed:33674826 ]
- Zhong A, Lee YH, Liu YN, Liu HW: Biosynthesis of Oxetanocin-A Includes a B12-Dependent Radical SAM Enzyme That Can Catalyze both Oxidative Ring Contraction and the Demethylation of SAM. Biochemistry. 2021 Feb 23;60(7):537-546. doi: 10.1021/acs.biochem.0c00915. Epub 2021 Feb 9. [PubMed:33560833 ]
|
|---|